Thank you — we'll be in touch shortly.

Welcome to the March 2026 edition of the 360 Clinical Research Consultancy Insights! In this issue, March Becomes the Implementation Month: What the UK’s Countdown Webinar Revealed

Welcome to the February 2026 edition of the 360 Clinical Research Consultancy Insights! In this issue, FDA’s One-Trial Default Changes the Conversation: What February 2026 Means for Drug Development Strategy.

Welcome to the January 2026 edition of the 360 Clinical Research Consultancy Insights! In this issue, UK Clinical Trial Competitiveness Becomes a 2026 Priority: Faster Assessments, Agile Regulation, and What It Means for Sponsors